Clinical Trial

Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With Schizophrenia

Completed
View on ClinicalTrials.gov →
Summary
Virtual reality (VR) is a novel and innovative intervention method increasingly used in psychiatric research and treatment. VR allows individuals to experience realistic, everyday social situations in a safe and controlled environment. This study aims to examine the effects of a cinematic VR-based psychosocial intervention on individuals with schizophrenia who experience reduced psychosocial functioning and social isolation. In this study, a Cinematic Virtual Reality Treatment Program (cVR-PTP) consisting of 12 weekly sessions was developed. Each session focuses on real-life social situations designed to support social interaction and daily functioning. The intervention aims to contribute to improvements in psychosocial functioning, social engagement, and overall functioning in individuals with schizophrenia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-24.
Trial Details
NCT Number NCT07326618
Lead Sponsor Dokuz Eylul University
Conditions Schizophrenia
Enrollment 37 participants
Start Date 2023-04-12
Primary Completion 2024-03-15 (estimated)
Study Completion 2024-09-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-12